Estratab combined with Prempro

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2001 Female 12/23/2005 United States
Primary
Secondary
Myocardial Infarction Other Serious 5/1/2002 46 Female 150 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/4/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/5/2001 49 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/21/1999 69 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/9/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/10/2002 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/17/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/24/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/16/1997 51 Female 129 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 3/21/2002 Female 3/1/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 3/21/2002 Female 3/6/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2002 66 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 2/8/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 64 Female 4/12/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 59 Female 6/13/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 55 Female 6/30/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 7/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2004 Female 7/17/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 7/16/2002 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 11/3/1999 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/2/2001 64 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/3/1999 Female 7/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2002 Female 8/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/17/2002 Female 8/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2000 Female 9/19/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2000 Female 9/22/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/15/2004 Female 10/2/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2003 Female 11/3/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2000 Female 11/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2002 Female 12/13/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/2002 Female 12/14/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2002 Female 12/13/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 Female 156 lb 12/30/2006 United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 2/4/2002 55 Female 173 lb 10/10/2006 United States
Primary
Secondary
Concomitant
Scar Other Serious 10/26/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 Female 165 lb 2/22/2007 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 198 lb 3/28/2007 United States
Primary
Secondary
Concomitant
Mastectomy Other Serious 1/25/2002 Female 11/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/6/2000 Female 4/5/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/18/2001 66 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 59 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/15/2004 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/3/1999 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/21/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/21/1999 63 Female 150 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/16/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 56 Female 264 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/23/1999 63 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/23/1999 65 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/5/2001 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 4/18/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 156 lb 2/7/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Required Intervention 12/1/2002 Female 7/5/2007 United States
Primary
Secondary
Visual Disturbance Other Serious 5/1/1993 56 Female 160 lb 8/4/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious Female 8/7/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/5/2002 Female 8/8/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/22/1999 Female 185 lb 8/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 10/8/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/13/2001 Female 10/23/2007 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 190 lb 11/3/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 8/1/2000 Female 11/20/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2000 Female 11/21/2007 Lawyer United States
Primary
Secondary
Vaginal Haemorrhage Other Serious 12/28/1998 58 Female 134 lb 9/17/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 7/8/2003 54 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/6/2000 Female 1/25/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/17/2000 57 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 4/18/2001 66 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 5/23/2002 63 Female 12/18/2007 United States
Primary
Secondary

Drug Data